SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018291
Filing Date
2023-11-08
Accepted
2023-11-08 16:30:38
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20230930x10q.htm   iXBRL 10-Q 2046219
2 EX-31.1 rytm-20230930xex31d1.htm EX-31.1 12989
3 EX-31.2 rytm-20230930xex31d2.htm EX-31.2 14731
4 EX-32.1 rytm-20230930xex32d1.htm EX-32.1 6991
5 EX-32.2 rytm-20230930xex32d2.htm EX-32.2 8085
  Complete submission text file 0001558370-23-018291.txt   6940462

Data Files

Seq Description Document Type Size
6 EX-101.SCH rytm-20230930.xsd EX-101.SCH 40175
7 EX-101.CAL rytm-20230930_cal.xml EX-101.CAL 59528
8 EX-101.DEF rytm-20230930_def.xml EX-101.DEF 158735
9 EX-101.LAB rytm-20230930_lab.xml EX-101.LAB 392177
10 EX-101.PRE rytm-20230930_pre.xml EX-101.PRE 275822
54 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20230930x10q_htm.xml XML 1053759
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 231388370
SIC: 2834 Pharmaceutical Preparations